Precigen Statistics
Total Valuation
Precigen has a market cap or net worth of $2.54 billion. The enterprise value is $2.60 billion.
| Market Cap | 2.54B |
| Enterprise Value | 2.60B |
Important Dates
The last earnings date was Tuesday, August 4, 2026, after market close.
| Earnings Date | Aug 4, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Precigen has 358.04 million shares outstanding. The number of shares has increased by 18.38% in one year.
| Current Share Class | 358.04M |
| Shares Outstanding | 358.04M |
| Shares Change (YoY) | +18.38% |
| Shares Change (QoQ) | +16.76% |
| Owned by Insiders (%) | 11.70% |
| Owned by Institutions (%) | 39.44% |
| Float | 194.65M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 12.60 |
| PS Ratio | 29.66 |
| Forward PS | 9.61 |
| PB Ratio | 58.33 |
| P/TBV Ratio | 98.53 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 30.36 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.58, with a Debt / Equity ratio of 2.26.
| Current Ratio | 4.58 |
| Quick Ratio | 3.76 |
| Debt / Equity | 2.26 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.06 |
Financial Efficiency
Return on equity (ROE) is -837.08% and return on invested capital (ROIC) is -34.97%.
| Return on Equity (ROE) | -837.08% |
| Return on Assets (ROA) | -18.14% |
| Return on Invested Capital (ROIC) | -34.97% |
| Return on Capital Employed (ROCE) | -28.02% |
| Weighted Average Cost of Capital (WACC) | 9.77% |
| Revenue Per Employee | $535,731 |
| Profits Per Employee | -$2.10M |
| Employee Count | 160 |
| Asset Turnover | 0.63 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +49.47% in the last 52 weeks. The beta is 1.02, so Precigen's price volatility has been similar to the market average.
| Beta (5Y) | 1.02 |
| 52-Week Price Change | +49.47% |
| 50-Day Moving Average | 6.21 |
| 200-Day Moving Average | 4.64 |
| Relative Strength Index (RSI) | 57.85 |
| Average Volume (20 Days) | 4,840,908 |
Short Selling Information
The latest short interest is 42.24 million, so 11.80% of the outstanding shares have been sold short.
| Short Interest | 42.24M |
| Short Previous Month | 42.04M |
| Short % of Shares Out | 11.80% |
| Short % of Float | 21.70% |
| Short Ratio (days to cover) | 8.20 |
Income Statement
In the last 12 months, Precigen had revenue of $85.72 million and -$336.71 million in losses. Loss per share was -$0.98.
| Revenue | 85.72M |
| Gross Profit | 45.44M |
| Operating Income | -39.50M |
| Pretax Income | -157.71M |
| Net Income | -336.71M |
| EBITDA | -35.36M |
| EBIT | -39.50M |
| Loss Per Share | -$0.98 |
Balance Sheet
The company has $38.21 million in cash and $98.35 million in debt, with a net cash position of -$60.14 million or -$0.17 per share.
| Cash & Cash Equivalents | 38.21M |
| Total Debt | 98.35M |
| Net Cash | -60.14M |
| Net Cash Per Share | -$0.17 |
| Equity (Book Value) | 43.58M |
| Book Value Per Share | 0.12 |
| Working Capital | 105.03M |
Cash Flow
In the last 12 months, operating cash flow was -$114.17 million and capital expenditures -$1.06 million, giving a free cash flow of -$115.22 million.
| Operating Cash Flow | -114.17M |
| Capital Expenditures | -1.06M |
| Depreciation & Amortization | 4.14M |
| Net Borrowing | 92.82M |
| Free Cash Flow | -115.22M |
| FCF Per Share | -$0.32 |
Margins
Gross margin is 53.01%, with operating and profit margins of -46.08% and -183.98%.
| Gross Margin | 53.01% |
| Operating Margin | -46.08% |
| Pretax Margin | -183.98% |
| Profit Margin | -183.98% |
| EBITDA Margin | -41.25% |
| EBIT Margin | -46.08% |
| FCF Margin | n/a |
Dividends & Yields
Precigen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.38% |
| Shareholder Yield | n/a |
| Earnings Yield | -13.25% |
| FCF Yield | -4.53% |
Analyst Forecast
The average price target for Precigen is $14.50, which is 104.23% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.50 |
| Price Target Difference | 104.23% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | 258.10% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Precigen has an Altman Z-Score of -12.66 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -12.66 |
| Piotroski F-Score | 4 |